177 related articles for article (PubMed ID: 38308202)
1. Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes.
Pravallika G; Rajasekaran R
BMC Genomics; 2024 Feb; 25(1):135. PubMed ID: 38308202
[TBL] [Abstract][Full Text] [Related]
2. A FTH1 gene:pseudogene:microRNA network regulates tumorigenesis in prostate cancer.
Chan JJ; Kwok ZH; Chew XH; Zhang B; Liu C; Soong TW; Yang H; Tay Y
Nucleic Acids Res; 2018 Feb; 46(4):1998-2011. PubMed ID: 29240947
[TBL] [Abstract][Full Text] [Related]
3. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
Saha SK; Jeong Y; Cho S; Cho SG
Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
[TBL] [Abstract][Full Text] [Related]
4. Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data.
Li D; Deng W; Huang G; Xiao X
Comb Chem High Throughput Screen; 2023; 26(11):1974-1989. PubMed ID: 36475339
[TBL] [Abstract][Full Text] [Related]
5. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.
Tian X; Song J; Zhang X; Yan M; Wang S; Wang Y; Xu L; Zhao L; Wei JJ; Shao C; Kong B; Liu Z
Cell Death Dis; 2020 Mar; 11(3):167. PubMed ID: 32127525
[TBL] [Abstract][Full Text] [Related]
6. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
Wu K; Zhang C; Zhang C; Dai D
Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
[TBL] [Abstract][Full Text] [Related]
7. Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.
Yan L; Yue C; Xu Y; Jiang X; Zhang L; Wu J
Med Sci Monit; 2020 May; 26():e921895. PubMed ID: 32457285
[TBL] [Abstract][Full Text] [Related]
8. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis.
Cao X; Wu B; Guo S; Zhong W; Zhu S; Zhang Z; Gu L; Li H
Pathol Oncol Res; 2023; 29():1610976. PubMed ID: 36969562
[No Abstract] [Full Text] [Related]
9. Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
Xing L; Zhang X; Guo M; Zhang X; Liu F
DNA Cell Biol; 2020 Apr; 39(4):709-723. PubMed ID: 32045271
[TBL] [Abstract][Full Text] [Related]
10. Pseudogenes and the associated ceRNA network as potential prognostic biomarkers for colorectal cancer.
Li Z; Zhou J; Gu L; Zhang B
Sci Rep; 2022 Oct; 12(1):17787. PubMed ID: 36272991
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers.
Chen J; Lou W; Ding B; Wang X
Aging (Albany NY); 2019 Aug; 11(15):5666-5688. PubMed ID: 31409759
[TBL] [Abstract][Full Text] [Related]
12. Transcribed pseudogene ψPPM1K generates endogenous siRNA to suppress oncogenic cell growth in hepatocellular carcinoma.
Chan WL; Yuo CY; Yang WK; Hung SY; Chang YS; Chiu CC; Yeh KT; Huang HD; Chang JG
Nucleic Acids Res; 2013 Apr; 41(6):3734-47. PubMed ID: 23376929
[TBL] [Abstract][Full Text] [Related]
13. TUSC2P suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and correlates with disease prognosis.
Liu F; Gong R; He B; Chen F; Hu Z
BMC Cancer; 2018 Sep; 18(1):894. PubMed ID: 30219035
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma.
Tan L; Qin Y; Xie R; Xia T; Duan X; Peng L; You R; Liu Y; Zou X; Zhang M; Lin M; Chen M
Theranostics; 2022; 12(17):7267-7288. PubMed ID: 36438489
[No Abstract] [Full Text] [Related]
15. Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma.
Du Y; Gao Y
BMC Cancer; 2020 Sep; 20(1):887. PubMed ID: 32938429
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of pseudogene HSPB1P1 and its potential roles in hepatocellular carcinoma.
Tang D; Zhao X; Zhang L; Wang C
J Cell Physiol; 2020 Oct; 235(10):6515-6527. PubMed ID: 31985034
[TBL] [Abstract][Full Text] [Related]
17. Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer.
Tutar Y; Özgür A; Tutar E; Tutar L; Pulliero A; Izzotti A
Biomed Pharmacother; 2016 Oct; 83():1182-1190. PubMed ID: 27551766
[TBL] [Abstract][Full Text] [Related]
18. Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity.
Green AM; DeWeerd RA; O'Leary DR; Hansen AR; Hayer KE; Kulej K; Dineen AS; Szeto JH; Garcia BA; Weitzman MD
EMBO Rep; 2021 Sep; 22(9):e52145. PubMed ID: 34347354
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma.
Gan W; Wang W; Li T; Zhang R; Hou Y; Lv S; Zeng Z; Yan Z; Yang M
J Cancer; 2022; 13(5):1588-1602. PubMed ID: 35371307
[No Abstract] [Full Text] [Related]
20. Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma.
Li Z; Dong K; Guo P; Tan Z; Zhang F; Tian Y; Lv H
Med Sci Monit; 2020 May; 26():e921855. PubMed ID: 32415055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
